97 results
Page 5 of 5
6-K
EX-99.1
k6d8vg 93vggw32
25 Jun 18
Aurinia Initiates Clinical Trials Broadening the Development of Voclosporin
11:32am
6-K
EX-99.1
z5c2wql
22 Jun 18
Aurinia Announces Results of Annual General Meeting
4:30pm
6-K
EX-99.2
izl7 mrgi4lsofr
10 May 18
Current report (foreign)
4:06pm
6-K
EX-99.1
x71 k8r38n8584ph
10 May 18
Aurinia Reports First Quarter Financial Results and Operational Highlights
4:03pm
6-K
EX-99.1
9pfha11h wo
20 Oct 17
Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome
12:00am
6-K
EX-99.1
935u6k
20 Apr 17
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
18juaq ubktm
21 Nov 16
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
0lv 3fzp6gvx85g8o4h
24 Oct 16
Aurinia Announces Acceptance of Late-Breaking Voclosporin Abstracts for Oral Presentation at Upcoming Medical Meetings
12:00am
6-K
EX-99.1
pyts4
6 Oct 16
Aurinia Releases Open-Label AURION Data Demonstrating Increased Remission Rates over Time for Voclosporin in the Treatment of Lupus Nephritis
12:00am
6-K
EX-99.1
xevbzqdpzg0ska1q
4 Feb 15
Aurinia Pharmaceuticals Inc. 6-K
12:00am
40FR12B/A
EX-99.25
q1s4gy
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.24
dwh0f4dt
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.15
vz1ow40sqgt
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.26
pxq 7o7wbvusel8i
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.16
lsel24
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.27
aolbfxg8z5c
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B
EX-99.1
hl1na
16 Apr 14
Initial registration of securities (Canada)
12:00am